ID: ALA4587414

Max Phase: Preclinical

Molecular Formula: C12H16N2O

Molecular Weight: 204.27

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)c1ccc2oc(CN)nc2c1

Standard InChI:  InChI=1S/C12H16N2O/c1-12(2,3)8-4-5-10-9(6-8)14-11(7-13)15-10/h4-6H,7,13H2,1-3H3

Standard InChI Key:  SIHHRUINFFFVPO-UHFFFAOYSA-N

Associated Targets(Human)

Lysyl oxidase homolog 2 834 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 204.27Molecular Weight (Monoisotopic): 204.1263AlogP: 2.58#Rotatable Bonds: 1
Polar Surface Area: 52.05Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.08CX LogP: 2.06CX LogD: 1.89
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.78Np Likeness Score: -1.20

References

1.  (2018)  Lysyl oxidase-like 2 inhibitors and uses thereof, 

Source